Figure 2.
Reverse cumulative distribution of poliovirus serotype 2 antibody titers at baseline and at the final visit (4 weeks after vaccination) for arms A (1-drop monovalent oral poliovirus vaccine type 2 [mOPV2]) and B (2-drop mOPV2).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.